Missouri Cardiovascular Specialists, LLP

Columbia, Missouri 65201

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Cardiovascular Disease, Coronary Artery Disease, High Bleeding Risk, Myocardial Infarction

Studies at this site

• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• LEADERS FREE II: BioFreedom™ Pivotal Study — Running, not enrolling
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early